Avenue Therapeutics Inc. buy krebskrebs
Start price
18.10.21
/
50%
€16.50
Target price
18.10.22
€30.00
Performance (%)
-76.27%
End price
19.10.22
€3.92
Summary
This prediction ended on 19.10.22 with a price of €3.92. Massive losses of -76.27% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Avenue Therapeutics Inc. | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
Comments by krebskrebs for this prediction
In the thread Avenue Therapeutics diskutieren
Buy mit Kursziel 2,0
In the thread Trading Avenue Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten